Tilray® receives the first and only market authorization to offer medical cannabis products in portugal

Nanaimo, british columbia--(business wire)--tilray, inc. (nasdaq: tlry), a global pioneer in cannabis research, cultivation, production, and distribution, today announced that it has received the necessary approvals and market authorization in accordance with the portuguese legislation to offer tilray medical cannabis products in portugal from its gmp-certified eu facility in cantanhede, portugal. the market authorization was issued by infarmed, the portuguese national authority of medicines an
TLRY Ratings Summary
TLRY Quant Ranking